Literature DB >> 1999334

Acatalasemia.

M Ogata1.   

Abstract

The abnormalities in acatalasemia at the gene level as well as properties of the residual catalase in Japanese acatalasemia are historically reviewed. The replacement of the fifth nucleic acid, guanine, in the fourth intron by adenine in the acatalasemic gene causes a splicing mutation and hence a deficiency of mRNA. The guanine-to-adenine substitution was detected in two Japanese acatalasemic cases from different families. The properties of the residual catalase are similar to those of normal catalase; the exons are identical. The properties of the residual catalase and the molecular defect in the catalase gene are compared among Japanese, Swiss, and mouse acatalasemias. The physiological role of catalase, as judged from human acatalasemic blood and acatalasemic mice, is also described.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1999334     DOI: 10.1007/bf00201829

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  57 in total

1.  Two cases of acatalasia in Switzerland.

Authors:  H AEBI; J P HEINIGER; R BUETLER; A HAESSIG
Journal:  Experientia       Date:  1961-10-15

2.  Nature of cultured cells of the skin from acatalasemic individuals with Takahara's disease.

Authors:  M Sadamoto
Journal:  Acta Med Okayama       Date:  1966-10       Impact factor: 0.892

3.  Absence of ethanol metabolism in "acatalatic" hepatic microsomes that oxidize drugs.

Authors:  K P Vatsis; M P Schulman
Journal:  Biochem Biophys Res Commun       Date:  1973-05-15       Impact factor: 3.575

4.  Mechanism of metallic mercury oxidation in vitro by catalase and peroxidase.

Authors:  M Ogata; H Aikoh
Journal:  Biochem Pharmacol       Date:  1984-02-01       Impact factor: 5.858

5.  Erythrocyte metabolism against oxidation in Japanese acatalasemia.

Authors:  S Takahara; M Ogata
Journal:  Monogr Hum Genet       Date:  1978

6.  [On the cellular distribution of catalase in the blood of homozygous and heterozygous defect-carriers (acatalasia)].

Authors:  H Aebi; M Cantz
Journal:  Humangenetik       Date:  1966

7.  Acatalasemic and hypocatalasemic mouse mutants.

Authors:  R N Feinstein; J B Howard; J T Braun; J E Seaholm
Journal:  Genetics       Date:  1966-05       Impact factor: 4.562

8.  The level and stability of residual catalase in cultured acatalasemic skin fibroblasts.

Authors:  M Ogata; Y Fujii; T Meguro; S Kira; A Matsuda; F Izushi; T Kimoto; S Takahara
Journal:  Acta Med Okayama       Date:  1987-10       Impact factor: 0.892

9.  Increased membrane binding of erythrocyte catalase in hereditary spherocytosis and in metabolically stressed normal cells.

Authors:  D W Allen; S Cadman; S R McCann; B Finkel
Journal:  Blood       Date:  1977-01       Impact factor: 22.113

10.  Erythrocyte catalase. A somatic oxidant defense?

Authors:  N S Agar; S M Sadrzadeh; P E Hallaway; J W Eaton
Journal:  J Clin Invest       Date:  1986-01       Impact factor: 14.808

View more
  16 in total

Review 1.  p53, oxidative stress, and aging.

Authors:  Dongping Liu; Yang Xu
Journal:  Antioxid Redox Signal       Date:  2011-02-07       Impact factor: 8.401

2.  Catalase -262C>T polymorphisms in Hungarian vitiligo patients and in controls: further acatalasemia mutations in Hungary.

Authors:  Zsuzsanna Kósa; Zsolt Fejes; Teréz Nagy; Melinda Csordás; Enikő Simics; Eva Remenyik; László Góth
Journal:  Mol Biol Rep       Date:  2011-09-24       Impact factor: 2.316

Review 3.  Human catalase: looking for complete identity.

Authors:  Madhur M Goyal; Anjan Basak
Journal:  Protein Cell       Date:  2010-11-09       Impact factor: 14.870

4.  Cloning and sequencing of a Candida albicans catalase gene and effects of disruption of this gene.

Authors:  D R Wysong; L Christin; A M Sugar; P W Robbins; R D Diamond
Journal:  Infect Immun       Date:  1998-05       Impact factor: 3.441

Review 5.  Catalase enzyme mutations and their association with diseases.

Authors:  László Góth; Péter Rass; Anikó Páy
Journal:  Mol Diagn       Date:  2004

6.  Animal model for oxidative stress research-Catalase mutant mice.

Authors:  Da-Hong Wang; Noriyoshi Masuoka; Shohei Kira
Journal:  Environ Health Prev Med       Date:  2003-05       Impact factor: 3.674

Review 7.  Evolution of catalases from bacteria to humans.

Authors:  Marcel Zamocky; Paul G Furtmüller; Christian Obinger
Journal:  Antioxid Redox Signal       Date:  2008-09       Impact factor: 8.401

8.  PharmGKB summary: methylene blue pathway.

Authors:  Ellen M McDonagh; José M Bautista; Ilan Youngster; Russ B Altman; Teri E Klein
Journal:  Pharmacogenet Genomics       Date:  2013-09       Impact factor: 2.089

Review 9.  PharmGKB summary: uric acid-lowering drugs pathway, pharmacodynamics.

Authors:  Ellen M McDonagh; Caroline F Thorn; John T Callaghan; Russ B Altman; Teri E Klein
Journal:  Pharmacogenet Genomics       Date:  2014-09       Impact factor: 2.089

10.  Influence of A-21T and C-262T genetic polymorphisms at the promoter region of the catalase (CAT) on gene expression.

Authors:  Khyber Saify; Iraj Saadat; Mostafa Saadat
Journal:  Environ Health Prev Med       Date:  2016-05-25       Impact factor: 3.674

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.